SWAN: Blitzscaling the early detection of skin cancer

Swan offers rapid, full-body dermoscopic skin cancer detection using advanced AI and imaging technologies, enhancing early diagnosis and treatment accessibility for all stakeholders.

Subsidie
€ 2.500.000
2022

Projectdetails

Introduction

Swan is a breakthrough solution to the enduring problem of detecting skin cancer early. For the first time, Swan enables full-body scanning at dermoscopic resolution and in less than 3 minutes to the benefit of all stakeholders: patients, physicians, hospitals, and payers.

Key Features

The solution captures key data that dermatologists acutely need for early diagnosis and brings breakthrough AI triage assistance to flag concerning lesions.

Benefits

Significant medical time is saved in the process and for patients, the impact is:

  • Faster access to treatment when needed
  • Fewer unnecessary biopsies
  • Peace of mind

Technology

The solution combines hardware and software and is at the crossroads of cutting-edge, patented technologies in:

  1. Real-time 3D human avatar generation
  2. Advanced robotic control
  3. Image processing
  4. AI classification of lesions

Ambition

Our ambition is to make best-in-class skin cancer screening accessible to everyone, everywhere and finally help dermatology make a quantum leap forward.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.500.000
Totale projectbegroting€ 3.920.366

Tijdlijn

Startdatum1-7-2022
Einddatum31-12-2024
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • SQUAREMINDpenvoerder

Land(en)

France

Vergelijkbare projecten binnen EIC Accelerator

EIC Accelerator

Pioneering diagnostics in dermatology and cancer

Dermagnostix aims to enhance dermatological diagnostics with a rapid, automated platform for precise molecular testing, reducing misdiagnoses and improving patient care.

€ 2.499.000
EIC Accelerator

Real-time multi-spectral imaging for accurate detection of cancerous tissue in endoscopic surgery

Thericon is developing an rMSI platform to enhance endoscopic cancer surgery by providing multi-parametric imaging for better tissue differentiation and reducing cancer recurrence, seeking funding for market launch in 2024.

€ 2.500.000
EIC Accelerator

Empowering Radiologists in Cancer Diagnostics with Artificial Intelligence

Better Medicine AI automates repetitive tasks in cancer CT scan analysis, reducing radiologist workload by 40-60% to improve diagnostic accuracy and address the radiologist shortage.

€ 2.499.875

Vergelijkbare projecten uit andere regelingen

Mkb-innovati...

Digital Skintyping Platform based on dermoscopy & AI

I-Parse ontwikkelt een digitaal platform dat AI gebruikt om huidtype te analyseren via dermatoscoopbeelden, met als doel het risico op huidkanker te verminderen en monitoring te verbeteren.

€ 18.888
Mkb-innovati...

SkinSight360

SkinSight360 onderzoekt de haalbaarheid van AI-gedreven dermatologische zorg en verbetert de communicatie tussen patiënten en dermatologen.

€ 20.000
ERC Proof of...

MUlti-spectral Scattering matrix for Enhanced skin imaging

The ERC REMINISCENCE project developed the DeepInsight microscope, enabling advanced non-invasive 3D imaging for early melanoma detection and skin disease analysis, with plans for commercialization.

€ 150.000
EIC Transition

Advancing stroke care with cutting-edge ultrasound biomarkers for Neurocritical Care

Resolve Stroke aims to enhance ultrasound imaging with the SYLVER system to improve stroke diagnosis and management through innovative biomarkers, making timely detection more accessible and effective.

€ 2.493.436
ERC Proof of...

Accurate quantification of neurologic disease over time

The project aims to develop CHRONOS, an AI-driven diagnostic tool using synthetic biomaps to enable earlier and more accurate detection of brain tumors, facilitating timely clinical decisions.

€ 150.000